EBS - Emergent BioSolutions raises 2025 guidance to $835M revenue and $210M EBITDA as international MCM sales surge
2025-10-29 20:57:24 ET
More on Emergent Biosolutions
- Emergent BioSolutions Inc. (EBS) Q3 2025 Earnings Call Transcript
- Emergent BioSolutions: Q2 Results Could Spark A Strong 2025 Rally
- Emergent BioSolutions Inc. (EBS) Q2 2025 Earnings Call Transcript
- Emergent Biosolutions Q3 2025 Earnings Preview
- Emergent Biosolutions secures $29M in MCM product orders from international government partner